Triacetyloleandomycin with triple sulfa. Its role in the control of staphylococcus and streptococcus infections in the urinary tract.
D004338:Drug Combinations; D009827:Oleandomycin / Q000031:analogs & derivatives; D013203:Staphylococcal Infections / Q000628:therapy*; D013210:Staphylococcus; D013290:Streptococcal Infections / Q000628:therapy*; D013291:Streptococcus; D013411:Sulfadiazine; D013416:Sulfamerazine; D013418:Sulfamethazine; D013449:Sulfonamides / Q000628:therapy*; D014217:Troleandomycin; D014552:Urinary Tract Infections / Q000628:therapy*; D000096926:Benzenesulfonamides
D004338:Drug Combinations; D009827:Oleandomycin; D013411:Sulfadiazine; D013416:Sulfamerazine; D013418:Sulfamethazine; D013449:Sulfonamides; D014217:Troleandomycin; C014873:trisulfapyrimidine; D000096926:Benzenesulfonamides
OLEANDOMYCIN/related compounds; STAPHYLOCOCCAL INFECTIONS/therapy; STREPTOCOCCAL INFECTIONS/therapy; SULFONAMIDES/therapy; URINARY TRACT INFECTIONS/therapy